Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06683833 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 18, 2026 (before its estimated May 3, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jul 20, 2025 to May 3, 2026
    • Start date changed from estimate of Nov 20, 2024 to Sep 3, 2025
    • Study sites: 0 to 1
    • Study completion date: Sep 20, 2025 to Jul 3, 2026
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cairo University
1,562 trials monitored
See 18 trials at risk
Compare the clinical performance and patient satisfaction of Egyptian MTA, Biodentine versus Calcium Hydroxide as indirect pulp capping materials in permanent teeth
Trial Details
NCT Number NCT06683833
Lead Sponsor Cairo University
Conditions
(from sponsor)		 Deep Caries, Indirect Pulp Capping, Mineral Trioxide Aggregate (MTA), Calcium Hydroxide, Biodentine, Patient Reported Outcome Measures
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov